Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Nitrendipine→

Nitrendipine Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
39562-70-4
Molecular formula
C18H20N2O6
Molecular weight
360.3612 g/mol
Drug class
Dihydropyridine L-type calcium-channel blockerantihypertensive
Mechanism of action
Inhibits L-type voltage-gated calcium channels in vascular smooth muscle, reducing transmembrane calcium influx and producing peripheral arterial vasodilation and lower blood pressure.
Indications / reported uses
  • Treatment of essential hypertension in adults in countries where nitrendipine is authorised; not a treatment for acute angina or acute hypertensive emergencies

Sources: NLM MeSH — Nitrendipine · PubMed — Nitrendipine clinical pharmacology · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Nitrendipine Environmental Risk Assessment (ERA) (the Nitrendipine ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.